» Articles » PMID: 32851592

Obesity Paradox and Heart Failure

Overview
Publisher Springer
Date 2020 Aug 28
PMID 32851592
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Background: There is scientific consensus that obesity increases the risk of cardiovascular diseases (CVD), including heart failure (HF). However, in CVD, many studies observed greater survival in overweight or class 1 obesity individuals. This counterintuitive observation was termed "obesity paradox" (OP).

Objective And Methods: This article is a narrative overview of the relationship between OP and CVD, particularly HF. The sources used were MEDLINE/PubMed, CINAHL, EMBASE, and Cochrane Library, from 2001 to 31 May 2020, exception for a 1983 work of historical importance. Studies reporting association and prognostic impact of obesity in HF and the impact of body composition on cardiac structure and myocardial function in obesity were also included in this review. In addition, we examined references from the retrieved articles and explored several related websites. Ultimately, we chose 79 relevant documents. Fifty-three were specifically focused on OP and HF.

Results: In this review, we made a summary of the evidence coming from a series of studies investigating OP. Many of these studies do not take into consideration or underestimate some of the more important morpho-functional variables of patients suffering from HF: among these, body composition and visceral adiposity, sarcopenic obesity, muscle fitness (MF), and cardiorespiratory fitness (CRF). A high body mass index (BMI) represents a risk factor for HF, but it also seems to exert a protective effect under certain circumstances. Fat distribution, lean mass, and cardio fitness could play an essential role in determining the observed differences in the HF population.

Conclusion: BMI does not distinguish between the metabolically healthy and metabolically unhealthy obesity. The obesity impact on morbidity and premature mortality can be underestimated and, therefore, may lead to incorrect clinical courses.

Level Of Evidence: Level V, Narrative review.

Citing Articles

L-shaped association between triglyceride-glucose body mass index and short-term mortality in ICU patients with sepsis-associated acute kidney injury.

Xu H, Mo R, Liu Y, Niu H, Cai X, He P Front Med (Lausanne). 2024; 11:1500995.

PMID: 39712174 PMC: 11659220. DOI: 10.3389/fmed.2024.1500995.


Lipoprotein(a) as a novel biomarker for predicting adverse outcomes in ischemic heart failure.

Zhang B, Xu Y, Huang X, Sun T, Ma M, Chen Z Front Cardiovasc Med. 2024; 11:1466146.

PMID: 39301496 PMC: 11410592. DOI: 10.3389/fcvm.2024.1466146.


Association between triglyceride glucose-body mass index and long-term adverse outcomes of heart failure patients with coronary heart disease.

Lyu L, Wang X, Xu J, Liu Z, He Y, Zhu W Cardiovasc Diabetol. 2024; 23(1):162.

PMID: 38724999 PMC: 11080126. DOI: 10.1186/s12933-024-02213-2.


Causal relationship between nutritional assessment phenotypes and heart failure: A Mendelian randomization study.

Chen Y, Yin M, Fan L, Jiang X, Xu H, Zhu X Heliyon. 2024; 10(7):e28619.

PMID: 38590862 PMC: 11000018. DOI: 10.1016/j.heliyon.2024.e28619.


Excessive fat expenditure in MCT-induced heart failure rats is associated with BMAL1/REV-ERBα circadian rhythmic loop disruption.

Ma D, Qu Y, Wu T, Liu X, Cai L, Wang Y Sci Rep. 2024; 14(1):8128.

PMID: 38584196 PMC: 10999456. DOI: 10.1038/s41598-024-58577-8.


References
1.
Hubert H, Feinleib M, MCNAMARA P, CASTELLI W . Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study. Circulation. 1983; 67(5):968-77. DOI: 10.1161/01.cir.67.5.968. View

2.
Capodaglio P, Liuzzi A . Obesity: a disabling disease or a condition favoring disability?. Eur J Phys Rehabil Med. 2013; 49(3):395-8. View

3.
Nallamothu B, Tommaso C, Anderson H, Anderson J, Cleveland Jr J, Dudley R . ACC/AHA/SCAI/AMA-Convened PCPI/NCQA 2013 Performance Measures for Adults Undergoing Percutaneous Coronary Intervention: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures, the Society for.... Circulation. 2013; 129(8):926-49. DOI: 10.1161/01.cir.0000441966.31451.3f. View

4.
Allison D, Downey M, Atkinson R, Billington C, Bray G, Eckel R . Obesity as a disease: a white paper on evidence and arguments commissioned by the Council of the Obesity Society. Obesity (Silver Spring). 2008; 16(6):1161-77. DOI: 10.1038/oby.2008.231. View

5.
Spelta F, Fratta Pasini A, Cazzoletti L, Ferrari M . Body weight and mortality in COPD: focus on the obesity paradox. Eat Weight Disord. 2017; 23(1):15-22. DOI: 10.1007/s40519-017-0456-z. View